Eyewire Today

Advertisement

EyewireTV — Eylea FDA Approval for DME, New Cassini Functionality, Simbrinza EU Approval

Video Thumnail

In this week's EyewireTV, Regeneron receives FDA approval for Eylea for the treatment of diabetic macular edema; and I-Optics launches a new functionality for its Cassini corneal shape analyzer that will allow the device to measure both anterior and posterior astigmatism. Also, leading cataract surgeons at the American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium in Deer Valley, Utah, discuss the potential to eliminate postoperative drops for pain and inflammation following cataract surgery.

Ocular Therapeutix Begins Sustained Release Travoprost Punctum Plug Feasibility Study to Treat Glaucoma

From Pharmabiz

Ocular Therapeutix, Inc., a Bedford, Massachusetts-based privately held company focused on the development and commercialization of ophthalmic therapeutic products,  has started sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma.

Login to read story

Wednesday, July 30, 2014

Show last days of articles

Johnson & Johnson Vision Care Offers Testimony to US Senate ...

From Johnson & Johnson Vision Care — 7/30/2014

Millicent Knight, OD, Head of Professional Affairs, Johnson & Johnson Vision Care, Inc. today appeared before a U.S. Senate sub-committee in Washi...Full story

RPS Welcomes Peter Grady as its New Chief Financial Officer

From Rapid Pathogen Screening — 7/30/2014

Rapid Pathogen Screening announced that Peter Grady has joined RPS as Chief Financial Officer, according to a company news release. Mr. Grady has more...Full story

Amgen Says It Will Cut More Than 2,400 Jobs Worldwide

From Bloomberg — 7/30/2014

Amgen Inc., the worlds biggest biotechnology company by sales, reported second-quarter earnings that beat analysts estimates and raised its profit est...Full story

Graduate Medical Education Needs Significant Overhaul: IOM

From Medscape Ophthalmology — 7/30/2014

It is time to overhaul how graduate medical education (GME) is financed and implemented in the United States to ensure that the public's $15 billion a...Full story

Researchers Detect Love and Lust Through Eye Movements

From Medical News Today — 7/30/2014

Have you ever experienced love at first sight? What about lust at first sight? Though these two different emotional and cognitive states are difficult...Full story

Tuesday, July 29, 2014

Wearable Device for the Early Detection of Common Diabetes-r...

From Applied Optics — 7/29/2014

A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it i...Full story

Study Links Loss of Vision to Employment Status

From Medical News Today — 7/29/2014

Unemployment has previously been found to have a strong connection with health and well-being. A new study published in JAMA Opthalmology has examined...Full story

Behavior Therapy May Help Prevent Depression Over Vision Los...

From Medscape Ophthalmology — 7/29/2014

For older people with central vision loss, combining occupational therapy with behavior therapy to keep them from becoming too isolated may prevent de...Full story

pSivida Announces Iluvien Receives Marketing Authorization i...

From pSivida Corp. — 7/29/2014

PSivida Corp. announced that Iluvien has been has granted marketing authorization in Norway for the treatment of vision impairment associated with chr...Full story

Monday, July 28, 2014

Alphaeon Acquires PRN Specialty Nutriceutical Company

From Alphaeon Corp. — 7/28/2014

Alphaeon Corp., a subsidiary of Strathspey Crown Holdings LLC, announced that it has acquired Physician Recommended Nutriceuticals (PRN...Full story

Deadline to Check Industry Payments to Docs Fast Approaching

From Medscape Ophthalmology — 7/28/2014

Physicians have until August 27 to review and challenge what drug and device makers have reported giving to them by way of cash or gifts as part of th...Full story

Alcon's Simbrinza Approved in the EU to Treat Patients With ...

From Alcon — 7/28/2014

Alcon announced that Simbrinza eye drops suspension (brinzolamide 10mg/mL and brimonidine tartrate 2mg/mL) has been approved by the European Commissio...Full story

Medicare Pressed to Bargain on Drug Costs

From Medpage Today — 7/28/2014

Medicare could save billions if Congress overcame its reluctance to anger the drug industry and allowed the program to demand rebates or negotiate pri...Full story

New Treatments On the Horizon to Treat Inherited Retinal Dis...

From Medical News Today — 7/28/2014

The National Institute for Health Research (NIHR) Horizon Scanning Centre (HSC), working with Fight for Sight, has identified 40 potential new treatme...Full story

Friday, July 25, 2014

I-Optics Announces New Cassini Total Corneal Astigmatism Fun...

From i-Optics — 7/25/2014

I-Optics will be launching new functionality for its Cassini corneal shape analyzer that will allow it to measure both anterior and posterior astigmat...Full story

Singapore Team Develops Asia's First Genetic Test That Can P...

From Medical Xpress — 7/25/2014

A team of eye doctors and scientists from Singapore have developed Asia's first genetic test for identifying patients with a type of eye disease that ...Full story

Robert E. Marc Named Recipient of 2014 Paul Kayser Internati...

From News-Medical — 7/25/2014

Robert E. Marc, PhD, director of research at the University of Utah's John A. Moran Eye Center, has been named by the International Society of Eye Res...Full story

Allergan Announces Ozurdex Receives European Positive Opinio...

From Allergan — 7/25/2014

Allergan announced that the European Unions Committee for Medicinal Products for Human Use (CHMP) has recommended extending the marketing authorizatio...Full story

TNF Inhibitor Therapy Effective for Behcet's Disease Uveitis

From Medscape Ophthalmology — 7/25/2014

When uveitis due to Behcet's disease fails to respond to conventional therapy, anti-TNF-alpha therapy may help, according to a Spanish study. Anti-TNF...Full story

Ocular Therapeutix Prices Initial Public Offering

From Ocular Therapeutix — 7/25/2014

Ocular Therapeutix announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $13 per ...Full story

Tumor Growth and Metastasis Controlled by New Drug Combo in ...

From Medical News Today — 7/25/2014

Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and me...Full story

More Years of School Correspond to More Nearsightedness

From Medscape Ophthalmology — 7/25/2014

More education was associated with a higher prevalence of nearsightedness in a study of more than 4500 people, and myopia worsened with additional yea...Full story

Advertisement

Featured Jobs
  • General Ophthalmologist

    , FL (Statewide)

    Established over 60 years ago, one of Floridas busiest and most respected practices is seeking an experience general ophthalmologist. Ideal candidate will have an interest and experience in glaucoma or light plastics as ...